Gastroesophageal Reflux Disease News and Research RSS Feed - Gastroesophageal Reflux Disease News and Research

Women who conceive babies through IVF at increased risk of experiencing GORD

Women who conceive babies through IVF at increased risk of experiencing GORD

Women who give birth to babies conceived by in-vitro fertilisation (IVF) are at increased risk of experiencing long-term symptoms of gastro-oesophageal reflux disease (GORD), according to the results of a study published in the UEG Journal. [More]
Mylan announces launch of Esomeprazole Magnesium Delayed-release Capsules USP in U.S.

Mylan announces launch of Esomeprazole Magnesium Delayed-release Capsules USP in U.S.

Mylan N.V. today announced the U.S. launch of Esomeprazole Magnesium Delayed-release Capsules USP, 20 mg and 40 mg, which is the generic version of AstraZeneca's Nexium. [More]
Proton pump inhibitors linked to increased risk of heart attack

Proton pump inhibitors linked to increased risk of heart attack

People who use proton pump inhibitors (PPIs) are up to 21% more likely to experience a heart attack than people who do not use the antacids, according to researchers from Stanford University, California. [More]
NGS mutational testing can help detect patients with Barrett's esophagus

NGS mutational testing can help detect patients with Barrett's esophagus

Barrett's esophagus (BE) develops in a subset of patients with gastroesophageal reflux disease (GERD) and can increase the risk of developing cancer of the esophagus. Although periodic surveillance for cancer is recommended for BE patients, these examinations may fail to identify pre-cancerous dysplasia and early cancers. [More]
Long-term treatment of GERD: an interview with Chris Rowland, CEO, Medigus

Long-term treatment of GERD: an interview with Chris Rowland, CEO, Medigus

To control reflux symptoms, many people take acid-controlling medications such as Proton Pump Inhibitors, or PPIs. The FDA, however, has issued warnings over the frequent or long-term continued use of PPIs... [More]
TWi signs Settlement Agreement with Takeda on patent litigation related to generic Dexilant

TWi signs Settlement Agreement with Takeda on patent litigation related to generic Dexilant

TWi Pharmaceuticals, Inc. today announced that it has entered into a Settlement Agreement with Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals America, Inc. (individually and collectively, "Takeda") to settle and dismiss all outstanding patent litigation related to TWi's generic dexlansoprazole delayed release capsules for oral administration in 30 mg and 60 mg dosage strengths. [More]
Incidence of esophageal cancer linked to GERD rises six-fold in recent decades

Incidence of esophageal cancer linked to GERD rises six-fold in recent decades

Esophageal cancer is one of the fastest-growing and deadliest cancers in the U.S. According to the American Cancer Society, an estimated 17,000 new cases of esophageal cancer will be diagnosed in 2015. Incidence of adenocarcinoma, a type of esophageal cancer linked to GERD (gastroesophageal reflux disease) has risen six-fold in recent decades. [More]
NPS MedicineWise program focuses on optimal use of PPI therapy in GORD patients

NPS MedicineWise program focuses on optimal use of PPI therapy in GORD patients

NPS MedicineWise today launches a new learning program and health professional tools on the use of proton pump inhibitors (PPIs) in the treatment of uncomplicated gastro-oesophageal reflux disease (GORD). [More]
Medigus announces completion of three MUSE procedures for GERD treatment in Italy

Medigus announces completion of three MUSE procedures for GERD treatment in Italy

Medigus Ltd., a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, announced the completion of three MUSE procedures in Italy by renowned gastroenterologist, Professor Pier Alberto Testoni, Director of Gastroenterology and Digestive Endoscopy IRCCS at San Raffaele Hospital in Milan. [More]
Loyola's Neil Gupta recommends patients to ask four questions when planning a colonoscopy

Loyola's Neil Gupta recommends patients to ask four questions when planning a colonoscopy

"Most people focus on the dislike of the preparation, the need to arrange transportation and the fear of being anesthetized during the procedure and then potentially getting a cancer diagnosis," says Neil Gupta, MD, MPH, Director of Endoscopy at Loyola University Health System. "Screening colonoscopy is a very critical examination that really can determine life and death when it comes to colon cancer. It is now clear that not every colonoscopy is equal. Once you've decided it's time to get a screening colonoscopy, the next step is to make sure that you get a high-quality one." [More]
MGH study suggests that bariatric surgery can reduce risk of asthma attacks

MGH study suggests that bariatric surgery can reduce risk of asthma attacks

A study led by Massachusetts General Hospital investigators suggests that bariatric surgery can significantly reduce the risk of asthma attacks - also called exacerbations - in obese patients with asthma. [More]
New standardized approach for feeding infants in NICU improves growth of babies

New standardized approach for feeding infants in NICU improves growth of babies

A new standardized approach for feeding infants in the neonatal intensive care unit (NICU) helps babies attain full oral feeds sooner, improves their growth and sends them home sooner. [More]
St. John Hospital first in Michigan to offer new alternative treatment for acid reflux disease

St. John Hospital first in Michigan to offer new alternative treatment for acid reflux disease

St. John Hospital is among the first in the state and the only site in southeast Michigan to offer a new alternative treatment for patients with acid reflux disease. [More]
Childhood obesity linked to higher risk of developing oesophageal cancer in later life

Childhood obesity linked to higher risk of developing oesophageal cancer in later life

Overweight children may be at higher risk of oesophageal (gullet) cancer when they grow up than their slimmer friends, according to research published this week in the British Journal of Cancer. [More]

Gastroenterology publishes landmark data from RESPECT study of Transoral Incisionless Fundoplication procedure

EndoGastric Solutions announces that Gastroenterology, the official journal of the American Gastroenterological Association Institute and the most prominent journal in the field of gastrointestinal disease, has published landmark data from the first-ever blinded, randomized, sham- and placebo-controlled clinical study of the Transoral Incisionless Fundoplication (TIF) procedure. [More]
Altos Therapeutics announces issuance of Mexican patent covering dopamine D2/D3 drug candidates

Altos Therapeutics announces issuance of Mexican patent covering dopamine D2/D3 drug candidates

Altos Therapeutics, LLC announced today that the Mexican Institute of Industrial Property has issued Patent Number 323020 titled, "D2 Antagonists, Methods of Synthesis and Methods of Use". The patent broadly and specifically covers the company's dopamine D2/D3 drug candidates, their pharmaceutical compositions, and their use to treat a number of important gastrointestinal conditions in humans, such as gastroparesis. [More]
First two patients enrolled in AGA’s GERD Registry successfully undergo treatment

First two patients enrolled in AGA’s GERD Registry successfully undergo treatment

The American Gastroenterological Association (AGA) Center for GI Innovation and Technology is pleased to announce that the first two enrollees in the STAR Registry — which seeks to compare laparoscopic surgery to an incisionless procedure to treat gastroesophageal reflux disease (GERD) — have successfully undergone treatment. [More]
AGA) Center for GI Innovation and Technology is pleased to announce that the first two enrollees in the STAR Registry

AGA) Center for GI Innovation and Technology is pleased to announce that the first two enrollees in the STAR Registry

The American Gastroenterological Association (AGA) Center for GI Innovation and Technology is pleased to announce that the first two enrollees in the STAR Registry — which seeks to compare laparoscopic surgery to an incisionless procedure to treat gastroesophageal reflux disease (GERD) — have successfully undergone treatment. [More]

US registry data shows long-term positive outcomes for GERD patients choosing TIF procedure

EndoGastric Solutions announced publication of US registry data showing that long-term gastroesophageal reflux disease (GERD) sufferers who underwent an incisionless procedure maintained symptom relief without the need to take proton pump inhibitor medicines for two years. [More]
Statins reduce patient's risk of developing Barrett's esophagus

Statins reduce patient's risk of developing Barrett's esophagus

Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. [More]
Advertisement
Advertisement